Molecular Mechanisms and Genetics of Autoimmunity COBRE
自身免疫 COBRE 的分子机制和遗传学
基本信息
- 批准号:8712643
- 负责人:
- 金额:$ 125.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-05 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:Autoimmune DiseasesAutoimmunityAwardBioinformaticsCapitalCenters of Research ExcellenceCore FacilityDataEffectivenessEquipmentFacultyFoundationsFundingFutureGeneticGenomicsGenotypeGrantGrowthInvestmentsLaboratoriesMedical ResearchMentorsMolecularMolecular GeneticsNucleic AcidsOklahomaPhasePilot ProjectsResearchResearch DesignResearch InfrastructureResearch PersonnelResearch Project GrantsScientistUnited StatesWagesbasecareerdata modelingmultidisciplinarynext generation sequencingprogramspublic health relevancestatisticssuccess
项目摘要
DESCRIPTION (provided by applicant): The Oklahoma Medical Research Foundation's ten-year COBRE, "Molecular Mechanisms and Genetics of Autoimmunity (GM 103456) has been transformative in providing the foundation for growth in understanding the molecular and genetic basis of autoimmune diseases in our state. This COBRE provided mentoring, funding and infrastructure support to launch multiple independent research careers and the awarding of "non-COBRE" program or center grants, greatly expanding the research base in Oklahoma. OMRF and Oklahoma can now legitimately claim to be a "Center" for Autoimmunity Genetics and Genomics in the United States. We now propose to develop to financial and operational independence two key research cores that were instrumental in our previous success. The Genomics core (formerly the Nucleic Acids Core) has been a component of this COBRE since it's beginning. Now equipped with next generation sequencing and high-throughput genotyping capability, this core generates the genomic data needed for the research projects of over 40 users. The Quantitative Analysis Core (QAC) was formed in year 10 through a merger of two existing cores, one focusing on statistics and the other on bioinformatics. The QAC provides COBRE investigators with access to an integrated group of data analysts, statisticians and bioinformaticists offering a full range of support from study design, power estimates, statistical analysis, and high dimensional data modeling. In addition to the research cores our COBRE Phase III supports Pilot Program and Administrative Cores. The pilot project core will identify, support and mentor COBRE eligible junior scientists through one year pilot projects. We view these pilot funds as a fundamental to our plans for the future of our genomics research base in Oklahoma. The Administrative core will provide administrative support to COBRE scientists, implement and expand multidisciplinary enrichment programs and evaluate the effectiveness of the pilot projects. OMRF will continue to partner with this COBRE through sustained and expanding support of salaries, capital equipment, laboratory space and faculty recruitment. We are confident that with Phase III COBRE support OMRF and Oklahoma will have an outstanding Genomics Center.
描述(由申请人提供):俄克拉荷马州医学研究基金会的十年研究报告“自身免疫的分子机制和遗传学(GM 103456)在为理解本州自身免疫性疾病的分子和遗传学基础方面的发展提供了变革性的基础。Cobre提供指导、资金和基础设施支持,以启动多个独立的研究事业,并授予“非Cobre”计划或中心赠款,极大地扩大了俄克拉何马州的研究基础。OMRF和俄克拉何马州现在可以合法地声称自己是美国的自身免疫遗传学和基因组学中心。我们现在建议开发财务和运营独立的两个关键研究核心,这两个核心对我们以前的成功起到了重要作用。基因组学核心(以前的核酸核心)从一开始就是这个Cobre的一个组成部分。现在配备了下一代测序和高通量基因分型能力,该核心生成了40多个用户的研究项目所需的基因组数据。量化分析核心(QAC)是在第10年由两个现有核心合并而成,一个侧重于统计,另一个侧重于生物信息学。QAC使Cobre研究人员能够接触到由数据分析师、统计学家和生物信息学家组成的综合团队,提供从研究设计、功率估计、统计分析和高维数据建模的全方位支持。除了研究核心,我们的Cobre第三阶段还支持试点计划和管理核心。试点项目核心将通过一年的试点项目确定、支持和指导符合科布雷条件的初级科学家。我们将这些试点基金视为我们在俄克拉何马州基因组研究基地未来计划的基础。管理核心将为Cobre科学家提供行政支持,实施和扩大多学科浓缩计划,并评估试点项目的有效性。OMRF将通过持续和扩大对工资、资本设备、实验室空间和教师招聘的支持,继续与Cobre合作。我们相信,在Cobre第三阶段的支持下,OMRF和俄克拉何马州将拥有一个出色的基因组学中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick M Gaffney其他文献
Patrick M Gaffney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick M Gaffney', 18)}}的其他基金
Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE
人类 SLE 的疾病和种族特异性单细胞表观遗传机制
- 批准号:
10612368 - 财政年份:2021
- 资助金额:
$ 125.87万 - 项目类别:
Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE
人类 SLE 的疾病和种族特异性单细胞表观遗传机制
- 批准号:
10397518 - 财政年份:2021
- 资助金额:
$ 125.87万 - 项目类别:
Epigenome-Guided Causal Variant Discovery and Mechanisms
表观基因组引导的因果变异发现和机制
- 批准号:
10158442 - 财政年份:2019
- 资助金额:
$ 125.87万 - 项目类别:
Epigenome-Guided Causal Variant Discovery and Mechanisms
表观基因组引导的因果变异发现和机制
- 批准号:
10408699 - 财政年份:2019
- 资助金额:
$ 125.87万 - 项目类别:
Epigenome-Guided Causal Variant Discovery and Mechanisms
表观基因组引导的因果变异发现和机制
- 批准号:
9753673 - 财政年份:2019
- 资助金额:
$ 125.87万 - 项目类别:
Epigenome-Guided Causal Variant Discovery and Mechanisms
表观基因组引导的因果变异发现和机制
- 批准号:
10618406 - 财政年份:2019
- 资助金额:
$ 125.87万 - 项目类别:
Epigenome-Guided Causal Variant Discovery and Mechanisms
表观基因组引导的因果变异发现和机制
- 批准号:
9925723 - 财政年份:2019
- 资助金额:
$ 125.87万 - 项目类别:
Molecular Mechanisms and Genetics of Autoimmunity COBRE
自身免疫 COBRE 的分子机制和遗传学
- 批准号:
8902227 - 财政年份:2014
- 资助金额:
$ 125.87万 - 项目类别:
相似海外基金
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 125.87万 - 项目类别:
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
- 批准号:
MR/Y033701/1 - 财政年份:2024
- 资助金额:
$ 125.87万 - 项目类别:
Research Grant
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
- 批准号:
MR/Y001273/1 - 财政年份:2024
- 资助金额:
$ 125.87万 - 项目类别:
Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
- 批准号:
478933 - 财政年份:2023
- 资助金额:
$ 125.87万 - 项目类别:
Operating Grants
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
- 批准号:
10760885 - 财政年份:2023
- 资助金额:
$ 125.87万 - 项目类别:
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
- 批准号:
10655219 - 财政年份:2023
- 资助金额:
$ 125.87万 - 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
- 批准号:
10582053 - 财政年份:2023
- 资助金额:
$ 125.87万 - 项目类别:
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
- 批准号:
490663 - 财政年份:2023
- 资助金额:
$ 125.87万 - 项目类别:
Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
- 批准号:
488982 - 财政年份:2023
- 资助金额:
$ 125.87万 - 项目类别:
Operating Grants
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
- 批准号:
2889164 - 财政年份:2023
- 资助金额:
$ 125.87万 - 项目类别:
Studentship